foscavir 24 mg/ml inf. sol. i.v. vial
clinigen healthcare b.v. - foscarnet trisodium hexahydrate 6 g/250 ml - solution for infusion - 24 mg/ml - foscarnet trisodium hexahydrate 24 mg/ml - foscarnet
vocarvi solution
sterimax inc - foscarnet sodium - solution - 24mg - foscarnet sodium 24mg - miscellaneous antivirals
foscavir 6g/250ml solution for infusion bottles
clinigen healthcare ltd - foscarnet sodium - solution for infusion - 24mg/1ml
telebrix 12 sodium
promedico ltd - sodium ioxitalamate - solution for injection - sodium ioxitalamate 21 g / 100 ml - ioxitalamic acid - ioxitalamic acid - contrast medium for retrograd cystography.
foscavir solution for infusion 24mg/ml
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - foscarnet trisodium, hexahydrate - solution for infusion - foscarnet trisodium hexahydrate 24 mg/ml - antivirals for systemic use
foscavir 24mg/ml solution for infusion
cherubino limited delf building, sliema road, gzira, gzr 1637, malta - foscarnet trisodium, hexahydrate - solution for infusion - foscarnet trisodium hexahydrate 24 mg/ml - antivirals for systemic use
foscavir, 24 mg/ml, solution for infusion
cherubino limited delf building, sliema road, gzira, gzr 1637, malta - foscarnet trisodium, hexahydrate - solution for infusion - foscarnet trisodium hexahydrate 24 mg/ml - antivirals for systemic use
ganciclovir sxp ganciclovir (as sodium) 500 mg powder for injection vial
southern cross pharma pty ltd - ganciclovir sodium, quantity: 546 mg (equivalent: ganciclovir, qty 500 mg) - injection, powder for - excipient ingredients: - ganciclovir sxp (ganciclovir) administered as the iv infusion is indicated for the palliative treatment of confirmed sight-threatening cytomegalovirus (cmv) disease in aids and other severely immunocompromised individuals. it is indicated for the treatment of confirmed cmv pneumonitis in bone marrow transplant patients. it is also indicated for the prophylaxis of cmv infection and disease following bone marrow and solid organ transplantation in patients at risk of cmv disease.,note: ganciclovir sxp (ganciclovir) is not indicated for congenital or neonatal cmv disease; nor for the treatment of cmv infection in non-immunocompromised individuals.
cefazolin pharmsol 1000 mg powder for solution for injection/infusion
pharmsol europe limited the victoria centre unit 2, lower ground floor, valletta road, mosta mst 9012 , malta - cefazolin sodium - powder for solution for injection/infusion - cefazolin sodium 1 g - antibacterials for systemic use
foscarnet bos solution for infusion
boston oncology arabia, saudi arabia - foscarnet - solution for infusion - 24 mg/ml